~15% Average body weight lost with semaglutide over 68 weeks NEJM STEP 1 Trial $149/mo Starting price transparent, no hidden fees MedLeanRx pricing Proven, consistent weight loss results Reduces hunger and food cravings Slows digestion for lasting fullness Well-established safety profile Ideal for first-time GLP-1 users Starting at $149/mo Physician-reviewed Tirzepatide Weight Loss in Austin Tirzepatide is a dual GIP/GLP-1 receptor agonist targeting two metabolic pathways for potentially stronger appetite suppression and greater weight loss results
i.e., weight maintenance and weight loss, in concomitance with a controlled intake of calories and improved physical activity, studies of three 68 weeks double-blind, placebo-controlled, randomized trials were conducted
Tesamorelin is a GHRH peptide that signals your body to release its own growth hormone, preferentially shrinking deep visceral belly fat while protecting lean muscle
Monitor for Side Effects Both semaglutide and Zofran can cause side effects, although they may not affect everyone
The discontinuation rate due to side effects is lower for Zepbound (9.1%) than for Retatrutide (11.2%), despite Retatrutides superior efficacy
4,145 reviews Hear what the journey actually looks like, in their words